Download

Download Full Text (451 KB)

Contents

  • Minimally Invasive Component Separation Reduces Wound-Healing Complications from Abdominal Surgery: Component separation, a major advance in abdominal wall reconstruction, can prevent hernia recurrence in many patients
  • Bevacizumab for Glioblastoma: Symptom Relief Proven, Overall Survival Benefit Being Studied-The antiangiogenic agent bevacizumab has been shown to prolong progression-free survival and ameliorate symptoms in patients with recurrent glioblastoma. However, it remains unknown whether bevacizumab should be used to treat newly diagnosed glioblastoma and whether bevacizumab prolongs the overall survival of patients with glioblastoma
  • HOUSE CALL: Hospice Care- Patients and families have choices for care and comfort
  • INBRIEF: Panobinostat Elicits Durable Response in Hodgkin Lymphoma

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Publication Date

6-1-2012

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston, Texas

Keywords

Rosen, Michael J. (Associate Professor of Surgery); Butler, C. E. (Charles E.); de Groot, John; Stark-Vance, Virginia; Ellis, Lee; Heymach, John; Heimberger, Amy; Abdominal Wound Closure Techniques; Minimally Invasive Surgical Procedures; Hernia; Bevacizumab; Glioblastoma; Antibodies, Monoclonal; Vascular Endothelial Growth Factors; Hospice Care; Hodgkin Disease; Panobinostat.

Disciplines

History of Science, Technology, and Medicine | Oncology

Conditions Governing Access

Open

OncoLog, Volume 57, Number 06, June 2012

Share

COinS